Bank Mandiri Persero Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Mandiri Persero Tbk trades at Rp4,200 (market cap 384.38T, 145.28M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bank Mandiri Persero Tbk is far larger — about 2296.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Mandiri Persero Tbk is more actively traded (145.28M versus 71K). Which is the better fit depends on your goals.
| BMRI | OBAT | |
|---|---|---|
Market Cap | 384.38T | 167.37B |
Volume | 145.28M | 71K |
Lot | 1.45M | 710 |
Turnover | 613.36B | 17.51M |
Average Price | 4,221.85 | 246.63 |
Value | 613.36B | 17.51M |
Indicative Equilibrium Price | 4,200 | 246 |
Indicative Equilibrium Volume | 138.7K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.
Read more on BMRI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →